Buy Price: $6.50 or better Sell Price: TradersPro Sell Signal Community Health Systems, Inc., through its subsidiaries, owns, leases, and operates general acute care hospitals in the United States. The company offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled […]
Read MoreIn the early stages of the arrival and spread of COVID-19 in the United States, I wrote in this space about my belief that one of the best places a smart investor should focus their attention is on healthcare stocks, including companies in the pharmacy space. This week has seen the pandemic take center stage, […]
Read MoreEver since coronavirus found its way to American shores, a large amount of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. From the market’s bearish low in […]
Read More“Coronavirus exhaustion” may not be a real term – but I do believe it’s a real thing. Over the last few months, it seems that there is real fatigue about hearing more news about COVID-19, vaccine trials, or the importance of hand washing and mask wearing. That comes in the face of increasing infection rates […]
Read MoreBuy Price: $64.50 or better Sell Price: TradersPro Sell Signal Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure.
Read MoreI seem to be noticing a new trend, not just among average consumers and investors, but even among people that I think should be hard-wired to know better, and that’s a desire to just write off 2020 and hit the reset switch. A lot of the commentary and debate among talking heads and market news […]
Read MoreThis week, I’ve turned my attention back to the Pharmacy industry – but specifically focusing on the distributors that supply the biggest pharmacies in the U.S. Understanding how some of those relationships work for a company you may have been following for a while can help identify new opportunities to think about. Over the last […]
Read MoreOne of the reasons I think the economy, and the financial markets are such a fascinating thing to watch is because of the way companies in different aspects of business relate to each other. It’s one thing to look at a retail store, for example and think about basic fundamental elements like sales, earnings, and […]
Read MoreSome of the early-morning market commentary today focused on the fact that with yesterday’s close, the S&P 500 has moved above its pre-pandemic high – leading those participating to call for the “official” end to the shortest bear market in history. While that may technically be true, it doesn’t automatically mean that investors should take […]
Read MoreIn the early stages of the arrival and spread of COVID-19 in the United States, I wrote in this space about my belief that one of the best places a smart investor should focus their attention is on healthcare stocks, including companies in the pharmacy space. Vaccine commentary and speculation continues to be a daily […]
Read More“Coronavirus exhaustion” may not be a real term – but I do believe it’s a real thing. There seems to be a real sense of exhaustion about the pandemic that is contributing to a number of factors in the United States – including, to some degree, the market’s seeming resilience and resistance over the last […]
Read MoreMost of us are certainly getting tired of continuing to hear and read about COVID-19. Daily statistics about infections, mortality rates, and rolling averages of both can really wear on even the most patient person. The truth, of course is that this isn’t something that is going to go away – not as long as […]
Read MoreThe market seems intent on rebounding from last week’s break in bullish momentum, with the major indices at the beginning of a new week all moving higher. That looks like another sign that investors generally want to emphasize the positive and be hopeful. Indications over the weekend that the federal government could approve a second […]
Read MoreMy approach to value-oriented investing can’t really be called pure value analysis. The main reason for that is because traditional value investing doesn’t worry about what a stock’s price has been doing; it is only concerned with what the stock’s price is now versus what the combination of fundamental and value metrics suggest it should […]
Read MoreIf you’re like me, you’re undoubtedly getting tired of the seemingly endless discussion and examination of COVID-19. Latest infection numbers, speculation about vaccine development progress, whether governments will reimpose restrictions or mandate common sense measures like wearing masks in public – let’s face it, it gets tiresome to be confronted with what appears to be […]
Read More